CI

Strategic Conclusion

• Recommendation: Buy
• Why? The technical picture is decisively bullish: SMA50 above SMA200, MACD above signal, and a perfect technical score. Analyst consensus leans Buy (1.97 mean, 26 buy vs 0 sell), and the P/E of 11.88 is reasonable for a health insurer, leaving room for upside. The price sits 8% below the 52-week high, suggesting momentum can carry it to retest that level.
• Ideal profile: Long-term investor with a 12–24 month horizon, or a swing trader looking to ride the uptrend. Not for those seeking deep value at the 52-week low.
• Price range: Entry zone $285–$295 (current level). Upside target $315–$320 (52-week high breakout). Stop-loss at $270 (below SMA200) to protect against trend reversal.
• Practical action: Buy now at market or on any dip toward $285. Add on a confirmed breakout above $315. Reduce position if price closes below $270.

1. Recent Price & Momentum

• Current price $290.05 is 8.1% below the 52-week high ($315.47) and 21.1% above the 52-week low ($239.51). This places the stock in the upper-middle of its yearly range, not at the top but clearly in an uptrend.
• Momentum is positive: the stock has recovered strongly from the low and is pressing toward the high. Short-term scenario: likely to test $300–$315 if buying pressure continues; a pullback to $280–$285 would be a normal consolidation, not a trend break.

2. Valuation (P/E)

• P/E TTM of 11.88 is below the typical large-cap health insurance sector average (often 14–18). This suggests the stock is not overvalued and may still be pricing in future growth at a discount.
• At this multiple, the market is not fully pricing in aggressive earnings expansion; the dividend yield of 1.74% adds a modest income cushion. Valuation supports a Buy, especially if earnings remain stable.

3. Technical Analysis

• SMA50 (283.53) is above SMA200 (279.79) — a golden-cross configuration confirming a medium-term uptrend.
• RSI(14) at 60.6 is neutral-to-strong, with room to run before overbought (70+).
• MACD (0.5489) is above its signal (-0.3390) with a positive histogram (0.8879) — clear bullish momentum.
• Technical score: 100/100 → BUY. All indicators align in favor of upward price movement.

4. Analyst Consensus

• Mean rating 1.97/5 (where 1 is Strong Buy and 5 is Strong Sell) translates to a "Buy" leaning rating. Distribution: 26 buy, 8 hold, 0 sell — no analyst recommends selling.
• This consensus aligns perfectly with the technicals: both point to continued upside. The only divergence is that analysts are slightly less aggressive than the technical score, but the overall signal is consistent: accumulate or hold, not exit.